본문으로 건너뛰기
← 뒤로

Time to adopt a new standard method for assessing cardiac function in chemotherapy-induced cardiotoxicity in breast cancer? A systematic review and meta-analysis.

메타분석 2/5 보강
Current problems in cardiology 2026 Vol.51(5) p. 103289 OA Chemotherapy-induced cardiotoxicity
TL;DR Comparative analysis of data from the meta-analyses supports the recommendation of Global Longitudinal Strain (GLS) as the preferred method for screening for cardiotoxicity, over isolated assessment by Left Ventricular Ejection Fraction (LVEF).
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-04-29
OpenAlex 토픽 · Chemotherapy-induced cardiotoxicity and mitigation Cancer Treatment and Pharmacology Breast Cancer Treatment Studies

Linhares BG, Linhares DG, Vale RGS, Gonçalves DM

📝 환자 설명용 한 줄

Comparative analysis of data from the meta-analyses supports the recommendation of Global Longitudinal Strain (GLS) as the preferred method for screening for cardiotoxicity, over isolated assessment b

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value p < .001
  • 95% CI 1.14 - 2.49
  • Sensitivity 74.6%
  • Specificity 76.3%
  • 연구 설계 systematic review

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Bruno Gama Linhares, Diego Gama Linhares, et al. (2026). Time to adopt a new standard method for assessing cardiac function in chemotherapy-induced cardiotoxicity in breast cancer? A systematic review and meta-analysis.. Current problems in cardiology, 51(5), 103289. https://doi.org/10.1016/j.cpcardiol.2026.103289
MLA Bruno Gama Linhares, et al.. "Time to adopt a new standard method for assessing cardiac function in chemotherapy-induced cardiotoxicity in breast cancer? A systematic review and meta-analysis.." Current problems in cardiology, vol. 51, no. 5, 2026, pp. 103289.
PMID 41616961

Abstract

[BACKGROUND] Anthracycline-induced cardiotoxicity is a major cause of morbidity in breast cancer survivors. Although left ventricular ejection fraction (LVEF) is the gold standard for monitoring cardiac function, it is often considered a late and insensitive marker of myocardial damage. New methods have emerged: global longitudinal strain (GLS) and cardiac magnetic resonance (CMR) derived parameters as potentially superior tools for detecting subclinical dysfunction. This study aimed to systematically compare the diagnostic accuracy and temporal sensitivity of GLS, LVEF, and CMR índices in the early detection of chemotherapy-induced cardiotoxicity.

[METHODS] A systematic review and meta-analysis of clinical studies was conducted to evaluate the outcomes and technical accuracy of the main methods for assessing cardiac function in breast cancer patients undergoing chemotherapy, using the PubMed, Web of Science, and Scopus databases. Twenty-nine studies were included in the systematic review and meta-analysis.

[RESULTS] The meta-analysis revealed a distinct temporal dissociation between methods. GLS detected a significant absolute reduction of 1.81% (95% CI: 1.14 - 2.49; z = 5.25, p < .001) as early as 1-3 months after treatment initiation. In contrast, LVEF showed a significant reduction of 3.59% only at mid-term follow-up (4-6 months), typically remaining within the range of clinical normality (>50%). The HSROC analysis for GLS (10 studies) demonstrated robust diagnostic performance, with an Area Under the Curve (AUC) of 0.818, a pooled sensitivity of 74.6% (95% CI: 64.8%-82.4%), and a specificity of 76.3% (95% CI: 68.2%-82.9%).

[CONCLUSION] Comparative analysis of data from our meta-analyses supports the recommendation of Global Longitudinal Strain (GLS) as the preferred method for screening for cardiotoxicity, over isolated assessment by Left Ventricular Ejection Fraction (LVEF).

MeSH Terms

Humans; Breast Neoplasms; Cardiotoxicity; Female; Antineoplastic Agents; Stroke Volume; Ventricular Function, Left; Anthracyclines; Magnetic Resonance Imaging, Cine